Pelvic radiation for early prostate cancer spread
Part of Cancer, Kidney & urinary clinical trials.
This study tests two different radiation approaches for men with prostate cancer that has returned after surgery and is found only in the pelvic lymph nodes. The goal is to see if one schedule is better at controlling the disease while limiting side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had surgery to remove your prostate (radical prostatectomy).
- Your PSA level has gone up to more than 0.2 after surgery, checked twice.
- A PSMA PET/CT scan shows cancer in lymph nodes inside the pelvis only (not in bones or other organs).
- You have not had radiation therapy to the prostate area before.
- You have not used hormone therapy (like Lupron or similar) in the last 6 months and your testosterone is normal.
- Your doctor expects you to live at least 5 more years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether giving radiation to all spots of cancer that show up on a PSMA PET scan works better than giving radiation only to the main tumor in the prostate. It is for men whose prostate cancer has spread to a few other places (up to 10 spots).
This study tests whether adding a type of high-precision radiation (MDRT) to standard hormone therapy works better for men with prostate cancer that has spread to just a few places. It is for patients who are newly diagnosed and on long-term hormone therapy.
This trial looks at radiation therapy given after prostate surgery (or if needed later) for prostate cancer where lymph nodes were not involved. It may help patients whose PSA rises or who need additional treatment to reduce the chance the cancer comes back.
This trial compares two ways of giving radiation to the prostate and pelvic lymph nodes. It also tests two different instructions for how full your bladder should be during treatment. The goal is to see which approach works better and is easier for patients.
This Phase 2 study compares two schedules of radiation treatment after prostate surgery in men whose PSA starts rising again. It aims to see which radiation approach works well while tracking quality of life and safety.
This Phase 2 trial tests a radiation-focused approach for people with newly diagnosed (de novo) prostate cancer that has spread to a small number of spots, especially in bone. It aims to see how well the treatment controls the cancer while keeping side effects manageable.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.